Biocon Insulin Plant Gets FDA Form 483s As Aspart Awaits Action

Six Observations Issued By US Agency Following On-Site Pre-Approval Inspection

 
• By David Wallace
  
Insulin Word Dictionary Needle
Biocon’s insulin aspart plant has received six Form 483 observations • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Business